Skip to main content
MEDIBANK PRIVATE LIMITED logo

MEDIBANK PRIVATE LIMITED — Investor Relations & Filings

Ticker · MPL ISIN · AU000000MPL3 LEI · BDYVSUPTML83OLINBJ17 ASX Financial and insurance activities
Filings indexed 515 across all filing types
Latest filing 2019-02-14 Regulatory Filings
Country AU Australia
Listing ASX MPL

About MEDIBANK PRIVATE LIMITED

https://www.medibank.com.au

Medibank Private Limited provides private health insurance and integrated health services. Operating through the Medibank and ahm brands, the organization offers hospital and extras insurance products tailored for individuals, families, and corporate clients. The company extends its core insurance business into health management, providing telehealth services, home-based care, and preventative health initiatives. Its service model emphasizes clinical support and digital health integration to enhance member wellbeing. By managing a broad network of healthcare providers, the organization focuses on delivering coordinated care and health support programs aimed at improving long-term health outcomes for its customer base.

Recent filings

Filing Released Lang Actions
HY19 Results - Investor Presentation 33 pages 4.8MB
Regulatory Filings
2019-02-14 English
Becoming a substantial holder 4 pages 272.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of initial substantial holder filed under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Schroder Investment Management Australia Limited in Medibank Private Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not a financial report, earnings release, or management report. It fits the category of Major Shareholding Notification filings.
2019-02-05 English
Key Dates 1 page 35.5KB
Report Publication Announcement Classification · 95% confidence The document is an ASX release announcing key dates related to the half-year period ended 31 December 2018, including the date for the 2019 Half Year Results Announcement and the interim dividend dates. It mentions a teleconference and webcast briefing for investors and analysts but does not contain any actual financial data or detailed financial statements. The document is short (1405 characters) and serves as a notification of upcoming events rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement about the report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2019-01-13 English
Full Federal Court dismisses ACCC appeal against Medibank 1
Legal Proceedings Report Classification · 95% confidence The document is an ASX release announcing the dismissal of ACCC legal proceedings against Medibank by the Full Federal Court. It contains no financial data, no report or financial statements, and is primarily a legal update and company statement. It is not a full audit report or legal proceeding report in detail, but rather a regulatory announcement about a legal matter. Given the content and nature, it fits best under Legal Proceedings Report (LTR). The document length is short and focused on legal outcome, not a financial or management report.
2018-12-19 English
Medibank's average premium increase lowest in 18 years 2 pages 106.6KB
Capital/Financing Update Classification · 90% confidence The document is an ASX release dated 19 December 2018 from Medibank Private Limited announcing the average premium increase for health insurance products and the early adoption of private health insurance reforms. It discusses premium changes, government reforms, and company cost-cutting measures. There are no financial statements, detailed financial data, or comprehensive report content. The document is a public announcement about pricing and policy changes rather than a full financial report or earnings release. It is also not a regulatory filing or certification. Given the content and length (4592 characters), it fits best as a Capital/Financing Update (CAP) because it relates to pricing changes and policy reforms impacting the company's financial outlook and customer premiums, which is a form of capital/financial update relevant to investors and the market.
2018-12-18 English
Appendix 3B - Issue of Securities - Performance Rights 8 pages 296.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, specifically Performance Rights, including the number of securities issued, terms, issue price, purpose, and quotation application to the ASX. It references ASX rules and compliance, and includes sections typical of a new issue announcement such as security class, issue dates, and quotation agreements. There is no financial performance data, management discussion, or audit information. The document is a formal announcement of a new securities issue and application for quotation, consistent with capital raising or share issuance disclosures. Therefore, it fits the category of Capital/Financing Update (CAP).
2018-12-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.